Acceleron Pharma Inc. Stock Analysis
Technical stock analysis for Tue 15'th Jan 2019
Acceleron Pharma Inc. fell by -5.43% in the last day from $46.44 to $43.92 and has now fallen 4 days in a row. The price has risen in 6 of the last 10 days and is up by 0.85% over the past 2 weeks. Volume has increased in the last day by 600 004 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 860 290 shares bought and sold for approximately $37.78 million.
Close price at the end of the last trading day (Tuesday, 15th Jan 2019) of the XLRN stock was $43.92. This is 5.43% less than the trading day before Monday, 14th Jan 2019.
During day the stock fluctuated 8.09% from a day low at $41.79 to a day high of $45.17.
30 day high of the XLRN stock price was $48.57 and low was $39.97.
90 day high was $59.08 and low was $39.97.
52 week high for the Acceleron Pharma Inc. - $59.59 and low - $32.53.
Acceleron Pharma Inc. lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.17% during the next 3 months and, with 90% probability hold a price between $31.79 and $41.59 at the end of this period.
There are few to none technical positive signals at the moment. Acceleron Pharma Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $46.36 and $46.47. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 10, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 56 and the stock is currently not being overbought or oversold
Support & Resistance
Acceleron Pharma Inc. finds support from accumulated volume at $43.36.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.38 between high and low, or 8.09%. For the last week, the stock has had a daily average volatility of 5.34%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Acceleron Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.
|XLRN $43.92 $-2.52(-5.43%)|
XLRN is down $2.52 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for XLRN based on the 1-3 month system that more than doubles the S&P 500.
Click here – the XLRN analysis is free »